Form 4: Zapata Quantum Director Granted 1 Million Stock Options

Zapata Quantum, Inc. director Clark Golestani was granted 1,000,000 stock options with an exercise price of $0.08, vesting over two years.

Summary

• Clark Golestani, a Director of Zapata Quantum, Inc. (ZPTA), was granted 1,000,000 stock options.
• The stock options have an exercise price of $0.08 per share.
• The grant date for these options was October 9, 2025.
• The options will vest in equal monthly increments over a two-year period.
• The first vesting date is scheduled for November 9, 2025.
• Vesting is contingent upon continued service as a director of the Issuer and the execution of the Issuer's Stock Option Agreement.
• The stock options expire on October 9, 2030.
• The grant was approved by the Issuer's Board of Directors, making it exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3.

Sentiment

Score: 6

Explanation: The grant of stock options to a director is a standard compensation practice aimed at aligning the director's interests with shareholder value creation. It is a routine disclosure and generally viewed as a positive for governance and incentivization, though it also represents potential future dilution.

Positives

• Aligns the director's financial interests with long-term shareholder value creation.
• Incentivizes continued service and performance from a key board member.

Negatives

• Represents potential future dilution for existing shareholders if the options are exercised.
• No immediate cash investment by the director, as it is a grant.

Risks

• The value of the options is dependent on Zapata Quantum's stock price exceeding the $0.08 exercise price in the future.
• Vesting is subject to Clark Golestani's continued service as a director, meaning the full benefit is not guaranteed if service ceases prematurely.

Future Outlook

The stock options are designed to vest over two years, aligning future performance with director retention and company growth. The value realization for the director depends on the company's future stock price performance exceeding the exercise price.

Management Comments

• The grant of stock options was approved by the Issuer's Board of Directors, exempting it from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3.

Industry Context

Granting stock options to directors is a common practice in publicly traded companies to align the interests of board members with those of shareholders, incentivizing long-term value creation and retention. This is particularly prevalent in growth-oriented sectors where equity compensation forms a significant part of overall remuneration.

Comparison to Industry Standards

• Equity compensation for directors is a standard practice across industries, particularly in technology and growth companies, to attract and retain talent.
• The specific terms, such as the exercise price and vesting schedule, would typically be benchmarked against peer companies of similar size and stage, though no specific benchmarks are provided in this filing.

Corporate Governance

Related Party Transactions

• Grant of 1,000,000 stock options to Clark Golestani, a Director of Zapata Quantum, Inc., as part of his compensation package. The options have an exercise price of $0.08 and vest over two years.

Stakeholder Impact

• Shareholders: Potential future dilution upon exercise of options; improved alignment of director's interests with long-term shareholder value.
• Employees: No direct impact mentioned.
• Management: No direct impact mentioned.

Next Steps

• Clark Golestani's continued service as a director of Zapata Quantum, Inc. for the options to vest.
• Execution of the Issuer's Stock Option Agreement by Clark Golestani.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a director as part of their compensation. While it aligns the director's interests with long-term shareholder value, it does not present new information that would fundamentally alter the investment thesis for Zapata Quantum, Inc. Therefore, a 'hold' recommendation is appropriate, pending further operational or financial updates.

Keywords

Zapata Quantum, ZPTA, Stock Options, Director Compensation, Equity Grant, Clark Golestani, Form 4, Insider Transaction